Literature DB >> 19829307

Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia.

P Y Jotta, M A Ganazza, A Silva, M B Viana, M J da Silva, L J G Zambaldi, J T Barata, S R Brandalise, J A Yunes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19829307     DOI： 10.1038/leu.2009.209

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  43 in total

1.  Synergistic activity of rapamycin and dexamethasone in vitro and in vivo in acute lymphoblastic leukemia via cell-cycle arrest and apoptosis.

Authors:  Chong Zhang; Yong-Ku Ryu; Taylor Z Chen; Connor P Hall; Daniel R Webster; Min H Kang
Journal:  Leuk Res       Date:  2011-12-03       Impact factor: 3.156

2.  Association of PTEN gene polymorphisms with liver cancer risk.

Authors:  Hong-Guang Li; Fang-Feng Liu; Hua-Qiang Zhu; Xu Zhou; Jun Lu; Hong Chang; Jin-Hua Hu
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

3.  PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature.

Authors:  Evgeni Efimenko; Utpal P Davé; Irina V Lebedeva; Yao Shen; Maria J Sanchez-Quintero; Daniel Diolaiti; Andrew Kung; Brian J Lannutti; Jianchung Chen; Ronald Realubit; Zoya Niatsetskaya; Vadim Ten; Charles Karan; Xi Chen; Andrea Califano; Thomas G Diacovo
Journal:  Mol Cancer Ther       Date:  2017-07-17       Impact factor: 6.261

4.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

5.  Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia.

Authors:  Monique Dail; Jason Wong; Jessica Lawrence; Daniel O'Connor; Joy Nakitandwe; Shann-Ching Chen; Jin Xu; Leslie B Lee; Keiko Akagi; Qing Li; Jon C Aster; Warren S Pear; James R Downing; Deepak Sampath; Kevin Shannon
Journal:  Nature       Date:  2014-07-20       Impact factor: 49.962

Review 6.  Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia.

Authors:  Chandrika Gowda; Mario Soliman; Malika Kapadia; Yali Ding; Kimberly Payne; Sinisa Dovat
Journal:  Adv Biol Regul       Date:  2017-06-13

Review 7.  The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.

Authors:  Rui D Mendes; Kirsten Canté-Barrett; Rob Pieters; Jules P P Meijerink
Journal:  Haematologica       Date:  2016-09       Impact factor: 9.941

Review 8.  Oncogenic PTEN functions and models in T-cell malignancies.

Authors:  M Tesio; A Trinquand; E Macintyre; V Asnafi
Journal:  Oncogene       Date:  2015-11-30       Impact factor: 9.867

9.  Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndrome.

Authors:  Ivana Gojo; Alexander Perl; Selina Luger; Maria R Baer; Kelly J Norsworthy; Kenneth S Bauer; Michael Tidwell; Stephanie Fleckinger; Martin Carroll; Edward A Sausville
Journal:  Invest New Drugs       Date:  2013-02-27       Impact factor: 3.850

10.  NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.

Authors:  Obul R Bandapalli; Martin Zimmermann; Corinne Kox; Martin Stanulla; Martin Schrappe; Wolf-Dieter Ludwig; Rolf Koehler; Martina U Muckenthaler; Andreas E Kulozik
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.